3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid

C102H97F10N19O18 — CID 159744139

IUPAC3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid
SMILESCN1CCC(n2c(NC(=O)c3cccc(C(F)F)c3)nc3cc(N4CCOCC4=O)ccc32)CC1.O=C(Nc1nc2cc(N3CCOCC3=O)ccc2n1CCCO)c1cccc(-c2ccn(C(F)F)c(=O)c2)c1.O=C(Nc1nc2cc(N3CCOCC3=O)ccc2n1CCCO)c1cccc(-c2ccn(CC(F)(F)F)c(=O)c2)c1.O=C(O)CCn1c(NC(=O)c2cccc(C(F)(F)F)c2)nc2cc(N3CCOCC3=O)ccc21
InChIInChI=1S/C28H26F3N5O5.C27H25F2N5O5.C25H27F2N5O3.C22H19F3N4O5/c29-28(30,31)17-34-9-7-19(14-24(34)38)18-3-1-4-20(13-18)26(40)33-27-32-22-15-21(35-10-12-41-16-25(35)39)5-6-23(22)36(27)8-2-11-37;28-26(29)34-9-7-18(14-23(34)36)17-3-1-4-19(13-17)25(38)31-27-30-21-15-20(32-10-12-39-16-24(32)37)5-6-22(21)33(27)8-2-11-35;1-30-9-7-18(8-10-30)32-21-6-5-19(31-11-12-35-15-22(31)33)14-20(21)28-25(32)29-24(34)17-4-2-3-16(13-17)23(26)27;23-22(24,25)14-3-1-2-13(10-14)20(33)27-21-26-16-11-15(28-8-9-34-12-18(28)30)4-5-17(16)29(21)7-6-19(31)32/h1,3-7,9,13-15,37H,2,8,10-12,16-17H2,(H,32,33,40);1,3-7,9,13-15,26,35H,2,8,10-12,16H2,(H,30,31,38);2-6,13-14,18,23H,7-12,15H2,1H3,(H,28,29,34);1-5,10-11H,6-9,12H2,(H,31,32)(H,26,27,33)
InChIKeyNCVFVRFPMLUJIV-UHFFFAOYSA-N
MW2066.99 g/mol
LogP13.68
Rot. Bonds27

About 3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid

3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid (PubChem CID 159744139) has the molecular formula C102H97F10N19O18 and a molecular weight of 2066.99 g/mol. Its IUPAC name is 3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid.

Molecular Properties

Compound Name3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid
PubChem CID159744139
Molecular FormulaC102H97F10N19O18
Molecular Weight2066.99 g/mol
Exact Mass2065.71
IUPAC Name3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid
SMILESCN1CCC(n2c(NC(=O)c3cccc(C(F)F)c3)nc3cc(N4CCOCC4=O)ccc32)CC1.O=C(Nc1nc2cc(N3CCOCC3=O)ccc2n1CCCO)c1cccc(-c2ccn(C(F)F)c(=O)c2)c1.O=C(Nc1nc2cc(N3CCOCC3=O)ccc2n1CCCO)c1cccc(-c2ccn(CC(F)(F)F)c(=O)c2)c1.O=C(O)CCn1c(NC(=O)c2cccc(C(F)(F)F)c2)nc2cc(N3CCOCC3=O)ccc21
InChIInChI=1S/C28H26F3N5O5.C27H25F2N5O5.C25H27F2N5O3.C22H19F3N4O5/c29-28(30,31)17-34-9-7-19(14-24(34)38)18-3-1-4-20(13-18)26(40)33-27-32-22-15-21(35-10-12-41-16-25(35)39)5-6-23(22)36(27)8-2-11-37;28-26(29)34-9-7-18(14-23(34)36)17-3-1-4-19(13-17)25(38)31-27-30-21-15-20(32-10-12-39-16-24(32)37)5-6-22(21)33(27)8-2-11-35;1-30-9-7-18(8-10-30)32-21-6-5-19(31-11-12-35-15-22(31)33)14-20(21)28-25(32)29-24(34)17-4-2-3-16(13-17)23(26)27;23-22(24,25)14-3-1-2-13(10-14)20(33)27-21-26-16-11-15(28-8-9-34-12-18(28)30)4-5-17(16)29(21)7-6-19(31)32/h1,3-7,9,13-15,37H,2,8,10-12,16-17H2,(H,32,33,40);1,3-7,9,13-15,26,35H,2,8,10-12,16H2,(H,30,31,38);2-6,13-14,18,23H,7-12,15H2,1H3,(H,28,29,34);1-5,10-11H,6-9,12H2,(H,31,32)(H,26,27,33)
InChIKeyNCVFVRFPMLUJIV-UHFFFAOYSA-N
XLogP13.68
TPSA430.84 Ų
H-Bond Donors7
H-Bond Acceptors28
Rotatable Bonds27
Heavy Atoms149
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002066.99
LogP ≤ 513.68
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1028

Analyze 3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-[1-(difluoromethyl)-2-oxopyridin-4-yl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide
CID 126688247
N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)pyridin-4-yl]benzamide
CID 126688392
3-[5-(3-Oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid
CID 126688484
N-[5-(4-acetyl-2-oxopiperazin-1-yl)-1-(3-hydroxypropyl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(2-oxopiperazin-1-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(2-oxo-1H-pyridin-4-yl)benzamide;N-[1-(3-hydroxypropyl)-5-(2-oxopiperazin-1-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
CID 157069870
3-(difluoromethyl)-N-[5-(2,2-dimethyl-3-oxomorpholin-4-yl)-1-(3-hydroxypropyl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(2-oxopiperidin-1-yl)benzimidazol-2-yl]benzamide;N-[5-(2,2-dimethyl-3-oxomorpholin-4-yl)-1-(3-hydroxypropyl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;N-[1-(3-hydroxypropyl)-5-(2-oxopiperidin-1-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
CID 157204950
3-cyano-N-[1-(4-hydroxycyclohexyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(4-hydroxybutyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(4-hydroxycyclohexyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-fluoro-N-[1-[[1-(hydroxymethyl)cyclopropyl]methyl]-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-5-(trifluoromethyl)benzamide
CID 157241685
3-cyano-N-[1-(4-hydroxycyclohexyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(4-hydroxycyclohexyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(4-hydroxycyclohexyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
CID 157309188
3-(difluoromethyl)-N-[1-(4-methylsulfinylbutyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(2-oxoimidazolidin-1-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-5-(trifluoromethyl)pyridine-3-carboxamide
CID 157314927
tert-butyl 4-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]piperidine-1-carboxylate;3-(difluoromethyl)-N-[1-[4-(hydroxymethyl)cyclohexyl]-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(1-hydroxypentan-3-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(1-hydroxypentan-3-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
CID 157346380
N-[5-(4-cyclopropyl-2-oxo-1,4-diazepan-1-yl)-1-(3-hydroxypropyl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;N-[5-(4-cyclopropyl-7-oxo-1,4-diazepan-1-yl)-1-(3-hydroxypropyl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(5-oxo-7-oxa-4-azaspiro[2.5]octan-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(2-oxo-1-pyridinyl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
CID 157372748
3-(difluoromethyl)-N-[5-(4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-1-(3-hydroxypropyl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[5-[4-(2-hydroxyethyl)-3,3-dimethyl-2-oxopiperazin-1-yl]-1-(3-hydroxypropyl)benzimidazol-2-yl]benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-5-(2-oxo-1-pyridinyl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(2-oxo-1-pyridinyl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
CID 157616507
3-(difluoromethyl)-N-[5-(2,2-dimethyl-3-oxomorpholin-4-yl)-1-(3-hydroxypropyl)benzimidazol-2-yl]benzamide;N-[5-(2,2-dimethyl-3-oxomorpholin-4-yl)-1-(3-hydroxypropyl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;N-[6-(4,4-dimethyl-2-oxo-1,3-oxazinan-3-yl)-1-(3-hydroxypropyl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;N-[1-(3-hydroxypropyl)-5-(2-oxopiperidin-1-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
CID 157792864

Frequently Asked Questions

What is the IUPAC name of 3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid?
The IUPAC name of 3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid (CID 159744139) is 3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid.
What is the SMILES notation for 3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid?
The canonical SMILES for 3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid is CN1CCC(n2c(NC(=O)c3cccc(C(F)F)c3)nc3cc(N4CCOCC4=O)ccc32)CC1.O=C(Nc1nc2cc(N3CCOCC3=O)ccc2n1CCCO)c1cccc(-c2ccn(C(F)F)c(=O)c2)c1.O=C(Nc1nc2cc(N3CCOCC3=O)ccc2n1CCCO)c1cccc(-c2ccn(CC(F)(F)F)c(=O)c2)c1.O=C(O)CCn1c(NC(=O)c2cccc(C(F)(F)F)c2)nc2cc(N3CCOCC3=O)ccc21.
What is the InChIKey of 3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid?
The InChIKey is NCVFVRFPMLUJIV-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H26F3N5O5.C27H25F2N5O5.C25H27F2N5O3.C22H19F3N4O5/c29-28(30,31)17-34-9-7-19(14-24(34)38)18-3-1-4-20(13-18)26(40)33-27-32-22-15-21(35-10-12-41-16-25(35)39)5-6-23(22)36(27)8-2-11-37;28-26(29)34-9-7-18(14-23(34)36)17-3-1-4-19(13-17)25(38)31-27-30-21-15-20(32-10-12-39-16-24(32)37)5-6-22(21)33(27)8-2-11-35;1-30-9-7-18(8-10-30)32-21-6-5-19(31-11-12-35-15-22(31)33)14-20(21)28-25(32)29-24(34)17-4-2-3-16(13-17)23(26)27;23-22(24,25)14-3-1-2-13(10-14)20(33)27-21-26-16-11-15(28-8-9-34-12-18(28)30)4-5-17(16)29(21)7-6-19(31)32/h1,3-7,9,13-15,37H,2,8,10-12,16-17H2,(H,32,33,40);1,3-7,9,13-15,26,35H,2,8,10-12,16H2,(H,30,31,38);2-6,13-14,18,23H,7-12,15H2,1H3,(H,28,29,34);1-5,10-11H,6-9,12H2,(H,31,32)(H,26,27,33).
What are the key properties of 3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid?
3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid has a molecular weight of 2066.99 g/mol, XLogP of 13.68, 27 rotatable bonds, 7 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(difluoromethyl)-N-[1-(1-methylpiperidin-4-yl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;3-[1-(difluoromethyl)-2-oxo-4-pyridinyl]-N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-[2-oxo-1-(2,2,2-trifluoroethyl)-4-pyridinyl]benzamide;3-[5-(3-oxomorpholin-4-yl)-2-[[3-(trifluoromethyl)benzoyl]amino]benzimidazol-1-yl]propanoic acid is sourced from PubChem (CID 159744139), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).